CSL to bring ‘next-generation’ mRNA flu vaccines to Australia – TOTT News
Australia’s biotech manufacturing giant, CSL, has signed a new $313 million deal to bring “next-generation” mRNA flu shots to our shores.| TOTT News
Australia’s biotech manufacturing giant, CSL, has signed a new $313 million deal to bring “next-generation” mRNA flu shots to our shores.| TOTT News
It has been revealed the United States is set to announce a major tariff on pharmaceutical imports, in a move that could rattle biopharma companies here in Australia.| TOTT News
